Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2047 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded890    
    Comments [Add]    
    Cited by others 8    

Recommend this journal


PSYCHIATRIC PEARLS Table of Contents   
Year : 2010  |  Volume : 52  |  Issue : 2  |  Page : 191-192
Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology

1 Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Ruhr-University, Bochum, Germany
2 Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Ruhr-University, Bochum; Department of Psychiatry and Psychotherapy, Philosophenweg: 3, University Hospital, Jena, Germany

Click here for correspondence address and email

Date of Web Publication22-Jun-2010

How to cite this article:
Ebert A, Bar KJ. Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology. Indian J Psychiatry 2010;52:191-2

How to cite this URL:
Ebert A, Bar KJ. Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology. Indian J Psychiatry [serial online] 2010 [cited 2022 Nov 28];52:191-2. Available from:

Emil Kraepelin was an influential German psychiatrist who lived in the late 19 th and the early 20 th century. His work had a major impact on modern psychiatry and its understanding of mental illnesses based on natural scientific concepts.

Kraepelin was born in 1856 in the small town of Neustrelitz in Northern Germany. Early residencies of his life were Leipzig and Wόrzburg, where he studied medicine as well as Munich, where he began his career as a psychiatrist before moving on to Leipzig again. Wilhelm Wundt, a well-known psychologist, philosopher and physiologist who met Kraepelin there, became a particularly influential person in Kraepelin's life. Kraepelin worked with enthusiasm in Wundt's laboratory in Leipzig where his dedication to scientific research became obvious. As a result of spending most of his time in the laboratory, he lost his position as a physician because of neglect of clinical work. After this short stay in Leipzig and his qualification as a university teacher, Kraepelin worked as a visiting professor for five years in Dorpat (Estonia) and later in Heidelberg (now as a regular professor). [1] In 1903, he moved to Munich where he founded the Department of Psychiatry of the University. It was his laboratory in which Alois Alzheimer studied the underlying causes of Alzheimer dementia. Emil Kraepelin died in 1926 in Munich after having dedicated his last years to the work on his psychiatric textbook (Lehrbuch der Psychiatrie) and the development of the Deutsche Forschungsanstalt fόr Psychiatrie (German Research Institute for Psychiatry).

One of the most important achievements of Emil Kraepelin was the connection of pathogenesis and manifestation of psychiatric disorders. [2] In opposition to the leading theories of his time, Kraepelin did not believe that certain symptoms were characteristic for specific illnesses. Clinical observation led him to the hypothesis that specific combinations of symptoms in relation to the course of psychiatric illnesses allow one to identify a particular mental disorder. Today his concept of endogenous psychosis is regarded as Kraepelin's main achievement. He differentiated between 'dementia praecox' and 'manic depression' as the two forms of psychosis. Kraepelin considered 'dementia praecox' (which is nowadays known as schizophrenia) as a biological illness caused by anatomical or toxic processes. [3] The reason for this denomination as dementia was that to Kraepelin; schizophrenia was a progressive neurodegenerative disease, which automatically resulted in irreversible loss of cognitive functions. In contrast, he described manic depression as an episodic disorder, which does not lead to permanently impaired brain function. In 1911, the Swiss psychiatrist Eugen Bleuler revised this idea, renaming 'dementia praecox' to schizophrenia. Nevertheless, the separation of affective disorders from schizophrenic psychosis as two distinct entities formed the basis for the understanding of psychiatric illnesses for more than a century. Over the last years both entities have been more and more regarded rather as a continuum than as two entirely distinct forms. [4] However, both the International Classification of Diseases (WHO) as well as APA's DSM-Classification still rely on Kraepelin's concept.

Although the dichotomic concept of psychosis is the best-known part of Kraepelin's psychiatric work, there are a lot more achievements to his credit. He pioneered in the field of psychopharmacological research, which was uncommon in his days. For instance, he combined testing subjects with substances like alcohol, caffeine and chloroform with psychological tests. [5] One of the most problematical issues about Kraepelin is his generalization of psychiatric findings to social and political contexts. For example, socialists and opponents of World War I were judged to be mentally ill by him. He also theorized about frequent genetic predispositions for psychiatric disorders in Jews. [6] In addition to that, Kraepelin did not become known as an empathetic psychiatrist during his daily work with patients; in his opinion it was more important to observe than to listen to patients' words. [7] This can also be seen as part of his struggle for objective observation and evidence. A matter of personal importance to him was his refusal not only of the abuse of alcohol, but also of alcohol in general. A possible explanation for this strong dislike might be that Kraepelin's father suffered from alcoholism, which severely affected his relationship to him.[7] Concerning psychotherapy, Kraepelin was in favor of a supportive approach. [8] Although Kraepelin and Sigmund Freud shared the same year of birth, in professional matters they can be regarded as antipodes. This signifies that with regard to Freud's psychoanalysis, Kraepelin always kept a highly critical point of view. Especially dream interpretation provoked his resistance; he judged psychoanalysis as not sufficiently based on scientific principles. Those different points of view still cause controversies nowadays when it comes to integrate natural scientific and psychodynamic understandings in psychiatry. In conclusion, he was a great thinker and started the scientific understanding of mental illness in a real sense.

   References Top

1.Gιraud M. Emil Kraepelin: A pioneer of modern psychiatry: On the occasion of the hundred and fiftieth anniversary of his birth. Encephale 2007;33:561-7.  Back to cited text no. 1      
2.Mφhler H. Emil Kraepelin un Neurowissenschaft heute. Vortrag anlδsslich der Verleihung der Kraepelin -Medaille in Gold am 26. November 2003. Max-Planck-Institut fόr Psychiatrie in Mόnchen.  Back to cited text no. 2      
3.Lehmann HE, Ban TA. The history of the psychopharmacology of schizophrenia. Can J Psychiatry 1997;42:152-62.  Back to cited text no. 3      
4.Demily C, Jacquet P, Marie-Cardine M. How to differentiate schizophrenia from bipolar disorder using cognitive assessment? Encephale 2009;35:139-45.  Back to cited text no. 4      
5.Mόller U, Fletcher PC, Steinberg H. The origin of pharmacopsychology: Emil Kraepelin's experiments in Leipzig, Dorpat and Heidelberg (1882-1892). Psychopharmacology (Berl) 2006;184:131-8.  Back to cited text no. 5      
6.Kraepelin E, Engstrom EJ. Psychiatric observations on contemporary issues. Hist Psychiatry 1992;3:253-69.  Back to cited text no. 6      
7.Decker HS. The psychiatric works of Emil Kraepelin: A many-faceted story of modern medicine. J Hist Neurosci 2004;13:248-76.  Back to cited text no. 7      
8.Goddemeier C. Deutsches Βrzteblatt, PP 5, Ausgabe February 2006, Seite 70.  Back to cited text no. 8      

Correspondence Address:
Karl-Jurgen Bar
Department of Psychiatry and Psychotherapy, University Hospital Jena, Philosophenweg 3, 07743 Jena
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5545.64591

Rights and Permissions

This article has been cited by
Hulya Ulugut, Calvin Trieu, Colin Groot, Jochum J. van ‘t Hooft, Betty M. Tijms, Philip Scheltens, Rik Ossenkoppele, Frederik Barkhof, Odile A. van den Heuvel, Yolande A.L. Pijnenburg
Biological Psychiatry. 2022;
[Pubmed] | [DOI]
2 Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review
Zubair Mahmood Kamal, Siddhartha Dutta, Sayeeda Rahman, Ayukafangha Etando, Emran Hasan, Sayeda Nazmun Nahar, Wan Farizatul Shima Wan Ahmad Fakuradzi, Susmita Sinha, Mainul Haque, Rahnuma Ahmad
Cureus. 2022;
[Pubmed] | [DOI]
3 Implementation of CCCP in Dissecting Classifications of Non- Criminal, Corporate and Criminal Psychopathy
Matthew Williams
Journal of Psychology and Neuroscience. 2021; : 63
[Pubmed] | [DOI]
4 Pratique clinique et pluralismes en psychiatrie
Christophe Gauld
Annales Médico-psychologiques, revue psychiatrique. 2021;
[Pubmed] | [DOI]
5 Antipsychotics, the heartland of clinical psychopharmacology?
Allan H Young, Sameer Jauhar
Journal of Psychopharmacology. 2021; 35(9): 1027
[Pubmed] | [DOI]
6 The Evolution of Approaches to Schizophrenia Diagnostics: from Kraepelin to ICD-11
Alexander B. Shmukler
Consortium Psychiatricum. 2021; 2(2): 65
[Pubmed] | [DOI]
7 Language and Communication Features of Childhood-Onset Schizophrenia and Autism Spectrum Disorders: A Literature Review
Tugçe ÇABUK, Sevket ÖZDEMIR, Gökhan TÖRET
Ankara Üniversitesi Egitim Bilimleri Fakültesi Özel Egitim Dergisi. 2021; : 1
[Pubmed] | [DOI]
8 Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms
Dominic A. Trevisan, Jennifer H. Foss-Feig, Adam J. Naples, Vinod Srihari, Alan Anticevic, James C. McPartland
Frontiers in Psychiatry. 2020; 11
[Pubmed] | [DOI]